Mathias Bressel

机构：The University of Melbourne, Peter MacCallum Cancer Centre · ORCID：0000-0002-9718-9596

发表论文 287 篇 · 总被引 6346 次 · h-index 43

代表论文

Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study (2024 · The Lancet Oncology · 被引 133)
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial (2024 · The Lancet Oncology · 被引 120)
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions (2024 · Blood · 被引 25)
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study (2024 · The Medical Journal of Australia · 被引 21)
Prognostic Value of Posttherapy SPECT/CT for Overall Survival in Patients Undergoing [ 177 Lu]Lu-PSMA-617 Radiopharmaceutical Therapy: Results from 3 Clinical Trials (2025 · Journal of Nuclear Medicine · 被引 18)
Stereotactic Ablative Body Radiotherapy for Oligoprogressive Estrogen Receptor–Positive Breast Cancer (TROG 20.03 AVATAR): A Phase II Prospective Multicenter Trial (2025 · JCO oncology advances. · 被引 14)